PeptideDB

D[LEU4,LYS8]-VP TFA

D[LEU4,LYS8]-VP TFA

CAS No.:

D[LEU4,LYS8]-VP TFA is a selective agonist of vasopressin V1b receptor, with Kis of 0.16 nM, 0.52 nM and 1.38 nM for rat
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

D[LEU4,LYS8]-VP TFA is a selective agonist of vasopressin V1b receptor, with Kis of 0.16 nM, 0.52 nM and 1.38 nM for rat, human and mouse V1b receptor respectively. D[LEU4,LYS8]-VP TFA has weak antidiuretic, vasopressor, and in vitro oxytocin activities.

Physicochemical Properties


Molecular Formula C49H68F3N11O13S2
Molecular Weight 1140.25
Related CAS # D[LEU4,LYS8]-VP;42061-33-6
Appearance White to off-white solid powder
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment, avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets vasopressin V1b receptor[1]
References

[1]. Pharmacological and physiological characterization of d[Leu4, Lys8]vasopressin, the first V1b-selective agonist for rat vasopressin/oxytocin receptors. Endocrinology. 2007 Sep; 148(9): 4136-46.

[2]. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8. J Med Chem. 2007 Feb 22; 50(4): 835-47.


Solubility Data


Solubility (In Vitro) DMSO :≥ 100 mg/mL (~87.70 mM)
H2O :~100 mg/mL (~87.70 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (2.19 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (2.19 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 0.8770 mL 4.3850 mL 8.7700 mL
5 mM 0.1754 mL 0.8770 mL 1.7540 mL
10 mM 0.0877 mL 0.4385 mL 0.8770 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.